BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $845,280 | -0.2% | 660,375 | +7.6% | 0.00% | – |
Q4 2023 | $846,824 | -52.2% | 613,641 | +5.4% | 0.00% | – |
Q3 2023 | $1,769,790 | -3.2% | 582,168 | +4.8% | 0.00% | – |
Q2 2023 | $1,827,908 | +149.5% | 555,595 | +141.2% | 0.00% | – |
Q1 2023 | $732,548 | -55.3% | 230,361 | -2.7% | 0.00% | – |
Q4 2022 | $1,639,099 | +6.1% | 236,864 | -2.9% | 0.00% | – |
Q3 2022 | $1,545,000 | -93.9% | 244,061 | -96.0% | 0.00% | -100.0% |
Q2 2022 | $25,420,000 | -14.6% | 6,140,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $29,779,000 | -51.5% | 6,140,000 | 0.0% | 0.01% | -50.0% |
Q4 2021 | $61,339,000 | -53.6% | 6,140,000 | -11.3% | 0.01% | -54.5% |
Q3 2021 | $132,222,000 | -40.3% | 6,918,987 | -0.0% | 0.02% | -40.5% |
Q2 2021 | $221,373,000 | +6.1% | 6,922,234 | +0.1% | 0.04% | 0.0% |
Q1 2021 | $208,552,000 | -9.9% | 6,917,143 | +29.3% | 0.04% | -14.0% |
Q4 2020 | $231,459,000 | -40.5% | 5,349,165 | -25.8% | 0.04% | -46.9% |
Q3 2020 | $389,100,000 | -12.0% | 7,212,227 | -0.4% | 0.08% | -17.3% |
Q2 2020 | $441,929,000 | +41.0% | 7,239,982 | +6.2% | 0.10% | +18.1% |
Q1 2020 | $313,461,000 | -52.2% | 6,820,314 | -8.8% | 0.08% | -39.9% |
Q4 2019 | $656,205,000 | -4.5% | 7,478,113 | -0.0% | 0.14% | -11.0% |
Q3 2019 | $686,969,000 | -25.5% | 7,481,680 | +3.2% | 0.16% | -24.0% |
Q2 2019 | $922,428,000 | -19.8% | 7,251,800 | -0.8% | 0.20% | -21.8% |
Q1 2019 | $1,150,349,000 | +56.9% | 7,311,700 | -1.1% | 0.26% | +41.8% |
Q4 2018 | $733,270,000 | +15.0% | 7,391,828 | +69.2% | 0.18% | +37.3% |
Q3 2018 | $637,675,000 | +37.8% | 4,367,629 | +48.1% | 0.13% | +30.1% |
Q2 2018 | $462,914,000 | +9.4% | 2,949,440 | +19.0% | 0.10% | +7.3% |
Q1 2018 | $423,057,000 | -14.8% | 2,477,635 | -11.1% | 0.10% | -12.7% |
Q4 2017 | $496,475,000 | -12.1% | 2,787,618 | -31.9% | 0.11% | -15.4% |
Q3 2017 | $564,957,000 | +43.5% | 4,091,827 | +9.5% | 0.13% | +41.3% |
Q2 2017 | $393,638,000 | +37.5% | 3,735,193 | +19.2% | 0.09% | +33.3% |
Q1 2017 | $286,238,000 | +52.1% | 3,134,861 | +2.8% | 0.07% | +46.8% |
Q4 2016 | $188,156,000 | +41.4% | 3,049,519 | +55.3% | 0.05% | +42.4% |
Q3 2016 | $133,096,000 | +48.1% | 1,963,639 | -5.4% | 0.03% | +43.5% |
Q2 2016 | $89,869,000 | +75.9% | 2,075,954 | +72.7% | 0.02% | +76.9% |
Q1 2016 | $51,095,000 | +8879.8% | 1,202,247 | +35469.4% | 0.01% | – |
Q2 2015 | $569,000 | -89.4% | 3,380 | -92.4% | 0.00% | -100.0% |
Q1 2015 | $5,385,000 | -39.9% | 44,589 | -54.3% | 0.00% | -50.0% |
Q4 2014 | $8,953,000 | – | 97,611 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
Baillie Gifford | 5,164,467 | $318,647,000 | 0.52% |